ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,240Medicare Part D Prescriptions Filled, Including Refills

Rank: 443 out of 6645

$794K Total Retail Price of All Prescriptions

Rank: 507 out of 6645

351 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 351 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

16% of this provider’s 351 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 11,189 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 524 449 1 4
NAMENDA 446 411 2 41
FUROSEMIDE 444 381 3 11
OMEPRAZOLE 420 349 4 6
AMLODIPINE BESYLATE 340 314 5 2
WARFARIN SODIUM 331 220 6 16
LISINOPRIL 290 264 7 3
SIMVASTATIN 279 177 8 1
METOPROLOL TARTRATE 252 222 9 13
DONEPEZIL HCL 250 250 10 27
METFORMIN HCL 249 183 11 7
POTASSIUM CHLORIDE 236 199 12 28
FAMOTIDINE 235 190 13 33
DIVALPROEX SODIUM 222 165 14 113
MIRTAZAPINE 219 197 15 70
MELOXICAM 201 178 16 46
GABAPENTIN 187 156 17 18
CARVEDILOL 184 172 18 25
HYDROCODONE-ACETAMINOPHEN 176 145 S3 19 5
PANTOPRAZOLE SODIUM 149 149 20 29
DIOVAN 137 137 21 19
EXELON 130 113 22 149
BUSPIRONE HCL 126 85 23 207
CARBIDOPA-LEVODOPA 124 124 24 116
LEVETIRACETAM 119 89 25 119
BENAZEPRIL HCL 118 116 26 21
LACTULOSE 111 86 27 125
TRAZODONE HCL 111 106 27 60
ALENDRONATE SODIUM 109 109 29 14
ATORVASTATIN CALCIUM 108 90 30 10
ROPINIROLE HCL 106 95 31 166
ZOLPIDEM TARTRATE 98 83 32 17
TRAMADOL HCL 95 78 33 30
ESCITALOPRAM OXALATE 94 76 34 86
MEGESTROL ACETATE 93 86 R 35 104
RISPERIDONE 92 92 36 93
IPRATROPIUM-ALBUTEROL 88 83 37 201
FENTANYL 86 80 S2 38 141
ATENOLOL 85 60 39 8
CYMBALTA 83 78 40 78
SEROQUEL XR 83 53 40 343
TAMSULOSIN HCL 80 68 42 22
CITALOPRAM HBR 80 70 42 35
JANTOVEN 78 27 44 336
CLOPIDOGREL 77 76 45 36
QUETIAPINE FUMARATE 77 64 45 101
METOPROLOL SUCCINATE 73 65 47 24
BACLOFEN 72 67 48 100
DIGOXIN 70 62 49 59
NEXIUM 68 46 50 40
GENERLAC 67 55 51 310
VALPROIC ACID 65 65 52 285
LYRICA 64 58 53 127
NOVOLOG 64 63 53 144
PREDNISONE 59 58 55 57
PRAVASTATIN SODIUM 57 55 56 20
CILOSTAZOL 57 39 56 202
LANTUS 55 53 58 50
LIDODERM 54 44 59 53
GLIPIZIDE 54 43 59 23
FLUTICASONE PROPIONATE 54 43 59 26
IPRATROPIUM BROMIDE 53 51 62 156
BUPROPION HCL 52 40 63 470
DIVALPROEX SODIUM ER 51 51 64 273
PLAVIX 51 51 64 49
HYDROCORTISONE 50 35 66 229
LOVASTATIN 50 48 66 15
CLONIDINE HCL 50 40 66 56
KLOR-CON 10 50 49 66 145
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.